Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interstitial cystitis and the overlap with overactive bladder.

Literature DB >> 22965225

Interstitial cystitis and the overlap with overactive bladder.

Christopher S Elliott¹, Christopher K Payne.

Abstract

The overlap between interstitial cystitis-painful bladder syndrome and overactive bladder can present a diagnostic challenge to the treating practitioner. Both can present with similar patient symptoms. Further compounding this dilemma is the fact that no gold standard test exists to differentiate one from the other. This review will serve to highlight their similarities and distinguishing features.

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22965225 DOI： 10.1007/s11934-012-0264-y

Source DB: PubMed Journal: Curr Urol Rep ISSN： 1527-2737 Impact factor: 3.092

65 in total

1. Reinvestigation of patients with a diagnosis of interstitial cystitis: common things are sometimes common.

Authors: Paul Irwin; Azizan Samsudin
Journal: J Urol Date: 2005-08 Impact factor: 7.450

2. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.

Authors: Antonella Giannantoni; Elisabetta Costantini; Savino M Di Stasi; Maria Cristina Tascini; Vittorio Bini; Massimo Porena
Journal: Eur Urol Date: 2006-01-04 Impact factor: 20.096

3. Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study.

Authors: A Kirkemo; M Peabody; A C Diokno; A Afanasyev; L M Nyberg; J R Landis; Y L Cook; L J Simon
Journal: Urology Date: 1997-05 Impact factor: 2.649

4. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis.

Authors: T C Chai; C Zhang; J W Warren; S Keay
Journal: Urology Date: 2000-05 Impact factor: 2.649

5. Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up.

Authors: Yahya Q Ghazwani; Mohamed S Elkelini; Magdy M Hassouna
Journal: Neurourol Urodyn Date: 2011-05-06 Impact factor: 2.696

Review 6. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.

Authors: Nazema Y Siddiqui; Jennifer M Wu; Cindy L Amundsen
Journal: Neurourol Urodyn Date: 2010 Impact factor: 2.696

7. Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes.

Authors: Christopher Payne; Tina Allee
Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696

Review 8. Muscarinic receptor antagonists for overactive bladder.

Authors: Paul Abrams; Karl-Erik Andersson
Journal: BJU Int Date: 2007-11 Impact factor: 5.588

9. Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome.

Authors: Patty Greenberg; Jessica Brown; Teresa Yates; Vivian Brown; Patricia Langenberg; John W Warren
Journal: Neurourol Urodyn Date: 2008 Impact factor: 2.696

10. Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS.

Authors: Richard E Berger; Marcia A Ciol; Ivan Rothman; Judith A Turner
Journal: BMC Urol Date: 2007-10-02 Impact factor: 2.264

10 in total

1. Immunomodulatory activity of orphan drug Elmiron® in female B6C3F1/N mice.

Authors: Sheetal A Thakur; Abraham Nyska; Kimber L White; Matthew J Smith; Wimolnut Auttachoat; Dori R Germolec
Journal: Food Chem Toxicol Date: 2014-03-20 Impact factor: 6.023

2. Pirt reduces bladder overactivity by inhibiting purinergic receptor P2X3.

Authors: Xiao-Fei Gao; Ji-Feng Feng; Wei Wang; Zheng-Hua Xiang; Xiu-Jie Liu; Chan Zhu; Zong-Xiang Tang; Xin-Zhong Dong; Cheng He
Journal: Nat Commun Date: 2015-07-07 Impact factor: 14.919

Review 3. Painful bladder syndrome: an update and review of current management strategies.

Authors: Anthony J Dyer; Christian O Twiss
Journal: Curr Urol Rep Date: 2014-02 Impact factor: 3.092

4. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.

Authors: H Henry Lai; Joel Vetter; Sanjay Jain; Robert W Gereau; Gerald L Andriole
Journal: J Urol Date: 2014-06-05 Impact factor: 7.450

5. Advances in diagnosis and treatment of interstitial cystitis/painful bladder syndrome.

Authors: Avinash Chennamsetty; Michael J Ehlert; Kenneth M Peters; Kim A Killinger
Journal: Curr Infect Dis Rep Date: 2015-01 Impact factor: 3.725

6. Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Authors: Alyssa Gracely; Anne P Cameron
Journal: Drugs Aging Date: 2020-10-23 Impact factor: 3.923

7. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder.

Authors: Emily Ma; Joel Vetter; Laura Bliss; H Henry Lai; Indira U Mysorekar; Sanjay Jain
Journal: Am J Physiol Renal Physiol Date: 2016-03-30

8. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.

Authors: Marianne Gamper; Volker Viereck; Jakob Eberhard; Jochen Binder; Carlo Moll; Joellen Welter; René Moser
Journal: Int Urogynecol J Date: 2013-05-14 Impact factor: 2.894

9. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.

Authors: Changcheng Guo; Bin Yang; Wenyu Gu; Bo Peng; Shengqiang Xia; Fengqiang Yang; Deyi Wen; Jiang Geng; Yuanyuan Zhang; Junhua Zheng
Journal: PLoS One Date: 2013-12-20 Impact factor: 3.240

10. Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment.

Authors: Aram Kim; Kyeong-Ok Hoe; Jung Hyun Shin; Myung-Soo Choo
Journal: Investig Clin Urol Date: 2017-08-03

10 in total